Timber Pharmaceuticals, Inc. reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported net loss was USD 9.5 million compared to USD 2.97 million a year ago. Basic loss per share from continuing operations was USD 7.5 compared to USD 4 a year ago.
For the six months, revenue was USD 0.083177 million compared to USD 0.429553 million a year ago. Net loss was USD 12.57 million compared to USD 4.84 million a year ago. Basic loss per share from continuing operations was USD 10 compared to USD 7 a year ago.